SBC Medical Q2 Revenue Beats, Net Income Surges 335% on AI Expansion
SBC sits 18% above its 52-week low of $2.78.
Summary
SBC Medical reported Q2 revenue of $49M, beating the $45.45M consensus, with net income up 335% YoY and EPS of $0.10. The company attributes growth to AI-powered support expansion and fee increases, with clinic count up 34 to 287. Management expects annual service fees to rise by about $15M if initiatives are realized. This follows a Q1 net income drop of 47% and governance issues, making this a significant positive turn. Watch for continued execution on U.S. and ASEAN expansion.
At the time of this announcement, SBC was trading at $3.29 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $329.1M. The 52-week trading range was $2.78 to $5.07. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Reuters.